Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty
Primary Purpose
Postoperative Pain, Hip Arthroplasty
Status
Unknown status
Phase
Phase 4
Locations
Denmark
Study Type
Interventional
Intervention
ropivacaine 0,2%
saline.9%
Sponsored by
About this trial
This is an interventional treatment trial for Postoperative Pain focused on measuring postoperative pain, total hip arthroplasty
Eligibility Criteria
Inclusion Criteria:
- scheduled for bilateral total hip arthroplasty
- able to speak and understand Danish
Exclusion Criteria:
- treatment with opioids or steroids
Sites / Locations
- Hviovre University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Hip 1
Hip 2
Arm Description
high volume local anesthetic infiltration
Outcomes
Primary Outcome Measures
postoperative pain
Secondary Outcome Measures
Full Information
NCT ID
NCT00864409
First Posted
March 17, 2009
Last Updated
March 17, 2009
Sponsor
Hvidovre University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00864409
Brief Title
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty
Study Type
Interventional
2. Study Status
Record Verification Date
March 2009
Overall Recruitment Status
Unknown status
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Hvidovre University Hospital
4. Oversight
5. Study Description
Brief Summary
High-volume infiltration analgesia may be effective in postoperative pain management following total hip arthroplasty. In this randomized, double-blind trial patients undergoing bilateral hip arthoplasty are randomized to receive high-volume local anesthetic infiltration in one hip and similar infiltration with saline (placebo) in the other hip.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain, Hip Arthroplasty
Keywords
postoperative pain, total hip arthroplasty
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
12 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Hip 1
Arm Type
Active Comparator
Arm Description
high volume local anesthetic infiltration
Arm Title
Hip 2
Arm Type
Placebo Comparator
Intervention Type
Drug
Intervention Name(s)
ropivacaine 0,2%
Intervention Description
Local wound infiltrtation with 170 mL ropivacaine 2 mg/mL
Intervention Type
Drug
Intervention Name(s)
saline.9%
Intervention Description
Wound infiltration with 170 mL sterile saline
Primary Outcome Measure Information:
Title
postoperative pain
Time Frame
0-48 hours postoperative
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
scheduled for bilateral total hip arthroplasty
able to speak and understand Danish
Exclusion Criteria:
treatment with opioids or steroids
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lasse Andersen, MD
Phone
+45 36323632
Email
lasse.oestergaard.andersen@hvh.regionh.dk
Facility Information:
Facility Name
Hviovre University Hospital
City
Hvidovre
ZIP/Postal Code
DK-2650
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lasse Andersen, MD
Phone
+45 36323632
Email
lasse.oestergaard.andersen@hvh.regionh.dk
12. IPD Sharing Statement
Learn more about this trial
Local Infiltration Analgesia With Ropivacaine Versus Placebo in Bilateral Hip Arthroplasty
We'll reach out to this number within 24 hrs